Avid Bioservices Inc (CDMO)

[biopharm]

11-9-15 SITC'15: New Bavi+Checkpoint Inhibitors preclin. data (UTSW/DUKE's Herbert K. Lyerly)

http://tinyurl.com/pbof95w

...Also, collab. with Dr. Bernard Fox (Immunotherapist/Earle A. Chiles Res.Inst.) on new Immuno-Profiling Clinical Test (Opal 6-plex quantitative IF Assay), PPHM roundtable with Raymond Birge (Rutgers), Douglas Graham (Emory), Dmitry Gabrilovich (Wistar), Rolf Brekken (UTSW), Maria Karasarides (AstraZeneca) - ”Combining Bavi w/anti-PD-1 significantly enhanced O/S… significant incr. CD45+, CD8+ and CD3+ T-cells… led a prolonged anti-tumor immune response which protected the animals against a re-challenge w/same tumor.”

--------------------------------------------------

Our very own biomarker dream team above.... including Dmitry Gabrilovich..... had some words of wisdom today re: MDSC's


Fri., Nov 18th
12:00 NOON
CCC, 10th Floor, CR10C

Cancer Biology Faculty
Candidate Seminar
Dmitry I. Gabrilovich, MD, PhD
The Wistar Institute
Philadelphia, Pennsylvania
TITLE: "Myeloid-derived suppressor cells in cancer are coming to age"

http://152.17.48.202/seminars.html